|

Alzheimer's Disease Clinical Trials in Mesa, AZ

32 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)Phase 35 mi
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)Phase 35 mi
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)Phase 35 mi
ACP-204 in Adults With Alzheimer's Disease PsychosisPhase 2/38 mi
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)Phase 38 mi
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)Phase 38 mi
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)Phase 38 mi
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's DiseasePhase 28 mi
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's DiseasePhase 28 mi
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisPhase 28 mi
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)Phase 28 mi
Arizona Alzheimer's Disease Research Center (ADRC)—8 mi
Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's DiseasePhase 28 mi
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)Phase 38 mi
A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease—8 mi
Trial-Ready Cohort-Down Syndrome (TRC-DS)—14 mi
A Study of AMDX-2011P in Participants With Alzheimer's DiseasePhase 214 mi
Early-Stage Partner in Care Living Alone PlusN/A14 mi
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesPhase 314 mi
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)Phase 314 mi
Repurposing Siponimod for Alzheimer's DiseasePhase 214 mi
[18F]PI-2620 Phase 3 Histopathological StudyPhase 314 mi
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's DiseasePhase 214 mi
Time Restricted Eating in Alzheimer's DiseaseN/A14 mi
PROMIS and Mobility Evaluation in Sarcoma Patients—14 mi
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)Phase 1/214 mi
Goal Setting to Promote Physical Activity Adherence in Midlife AdultsN/A14 mi
Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies—14 mi
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseasePhase 314 mi
A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness ResponsesN/A14 mi
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseasePhase 328 mi
Longitudinal Early-onset Alzheimer's Disease Study Protocol—28 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.